Answers are grounded in this paper and cite their sources.
The 2-gene based urine assay, which is optimized for biopsy naïve patients with serum prostate specific antigen less than 10 ng/ml, demonstrated high sensitivity and negative predictive value to detect clinically significant prostate cancer. These data support using the test to help guide initial prostate biopsy decisions.
No takes yet. Share an insight, caveat, or question.
Haese et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: